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Abstract The receptor mechanisms regulating the ATP-in-
duced free cytosolic Ca2+ concentration ([Ca2+]i) changes in
cultured rat cortical type-1 astrocytes were analyzed using
fura-2-based Ca2+ imaging microscopy. Upon prolonged ATP
challenge (1^100 WM), astroglial cells displayed a biphasic
[Ca2+]i response consisting of an initial peak followed by a
sustained elevation. Suramin and pyridoxalphosphate-6-azo-
phenyl-2P,4P-disulfonic acid blocked both components, albeit to
a di¡erent extent. By contrast, the selective P2X7 antagonist
oxidized ATP irreversibly abrogated the sustained [Ca2+]i signal
without a¡ecting the transient phase. Finally, astrocyte chal-
lenge with the selective P2X7 agonist 3P-O-(4-benzoyl)benzoyl-
ATP evoked a sustained [Ca2+]i elevation, which occluded that
induced by ATP. We can conclude that in cultured cortical
astrocytes the ATP-mediated sustained [Ca2+]i rise does not
implicate capacitative Ca2+ entry but involves Ca2+ in£ux
through P2X7-like receptors.
6 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Astrocytes are involved in multiple brain functions in phys-
iological conditions, participating in neuronal development,
synaptic activity and homeostatic control of the extracellular
milieu [1]. Following pathological insults such as stroke, trau-
ma and seizures as well as as a result of chronic neurological
disorders (e.g. Alzheimer’s disease and amyotrophic lateral
sclerosis) astroglial cells undergo a vigorous activation, called
reactive gliosis, which is characterized by increased cell pro-
liferation and hypertrophy [2]. Several lines of evidence sug-
gest that increased extracellular ATP, released from damaged
or dying cells, may be implicated in promoting astrogliosis
through stimulation of P2 purinoceptors [3,4]. Notably,
ATP was shown to stimulate astrocyte proliferation upon ac-
tivation of P2 receptors also in situ [5].
Activation of di¡erent subtypes of P2Y metabotropic recep-
tors leads to the elevation of free cytosolic Ca2þ concentration
([Ca2þ]i) mediated by phosphoinositide turnover-dependent
Ca2þ release from intracellular organelles [6]. In di¡erent
cell preparations this P2Y-mediated Ca2þ mobilization is ac-
companied by a substantial Ca2þ in£ux from the extracellular
space via a pathway that is commonly referred to as capaci-
tative Ca2þ entry (CCE), which is mediated by the opening of
store-operated Ca2þ channels [7].
Although current models of receptor-activated Ca2þ entry
focus on the capacitative mechanism, there is increasing evi-
dence that this pathway is not the only one whereby Ca2þ can
enter into the cells in response to activation of membrane
receptors [8^10]. Recently, ionotropic P2 purinoceptors
(P2X7) permeable to Ca2þ were functionally characterized in
di¡erent cell types [6,11]. Hence, because of the complexity of
the P2 purinoceptor-mediated [Ca2þ]i signalling, dissecting the
relative contribution of the di¡erent [Ca2þ]i-elevating path-
ways in each cellular context is of crucial importance in the
attempt to determine the biological signi¢cance of the mech-
anisms regulating the intracellular Ca2þ homeostasis.
Astroglial cells express a variety of receptors for neuro-
transmitters and cell modulators, many of which are coupled
to [Ca2þ]i rise via the phospholipase C/inositol triphosphate
(PLC/IP3) pathway [12,13]. Although CCE seems to be opera-
tional also in astroglia [14,15], the precise relationship be-
tween receptor activation, Ca2þ store depletion, and stimula-
tion of Ca2þ entry has not been explored yet. Astrocytes both
in vitro and in situ express PLC-coupled P2Y receptors [16].
Moreover, there is accumulating evidence that also astroglial
cells possess P2X7 receptor, whose functional role, however,
remains to be fully elucidated [17^20].
In the present study, we investigated the interplay between
activation of ATP receptors, Ca2þ release from intracellular
stores and Ca2þ entry across the plasma membrane in cul-
tured rat cortical type-1 astrocytes. We were able to demon-
strate that the sustained [Ca2þ]i increase observed following
the transient [Ca2þ]i signal elicited upon stimulation of P2
purinoceptors with low micromolar concentrations of ATP
is not mediated by CCE but is the result of extracellular
Ca2þ in£ux through P2X7-like receptors.
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2. Materials and methods
2.1. Cell culture
Primary cultures of pure cortical rat astrocytes were prepared as
previously described [21]. Brie£y, cerebral cortices of 1^2-day-old
pups devoid of meninges were triturated and placed in cell culture
£asks containing DME-glutamax medium with 15% fetal calf serum
and penicillin/streptomycin (100 U/ml and 100 Wg/ml, respectively).
Culture £asks were maintained in a humidi¢ed incubator with 5%
CO2 for 2^5 weeks. At con£uence, astroglial cells were enzymatically
dispersed (trypsin-EDTA) and replaced in 20-mm glass coverslips at a
density of 5U103 per coverslip. All experiments were performed at
room temperature (20^22‡C) at day 3^8 after replating. Immunostain-
ing for glial ¢brillary acidic protein and the £at, polygonal shape of
the cultured cells indicated that more that 95% were type-1 cortical
astrocytes. For the preparation of the astrocytic cultures, all the ma-
terials used were from Gibco-BRL (Invitrogen, Italy). No evidence
was found for variability in receptor properties over the period of
cell culturing.
2.2. Solutions
During the experiments, the cells were continuously superfused us-
ing a multiple perfusion system allowing a £ux of about 2.5 ml/min.
The extracellular solution contained (mM): 135 NaCl, 5.4 KCl, 1.8
CaCl2, 1 MgCl2, 5 HEPES and 10 glucose (pH adjusted to 7.4 with
NaOH). Ca2þ-free extracellular solution was prepared by replacing
CaCl2 with equimolar amounts of MgCl2 and by adding 0.5 mM
EGTA. The salt solutions and the chemicals for the £uorimetric de-
termination of the [Ca2þ]i responses were obtained from Sigma-Al-
drich Italy.
2.3. Imaging and data analysis
Intracellular calcium was monitored using the £uorescent Ca2þ in-
dicator fura-2 AM. Cultures were loaded in extracellular solution (see
above) supplemented with 10 WM fura-2 AM for 45 min at 37‡C.
Measurements of [Ca2þ]i of single cells were performed by using an
inverted £uorescence microscope Nikon TE200 (Nikon, Tokyo, Ja-
pan) equipped with a dual excitation £uorometric imaging system
(Hamamatsu, Sunayama-Cho, Japan). The excitation wavelength
was alternated between 340 and 380 nm, and the emission £uores-
cence of selected astrocytes was passed through a 510-nm narrow-
band ¢lter and recorded with a digital CCD camera Hamamatsu
C4742-95-12ER. Monochromator settings, chopper frequency and
complete data acquisition were controlled by Aquacosmos/Ratio soft-
ware U7501-01 (Hamamatsu). The sampling rate was 0.25 or 0.5 Hz.
At the end of each set of experiments, cells were permeabilized using
the calcium ionophore 4-bromo-A23187 (20 WM) and the background
£uorescence determined after exposure of the cells to an extracellular
solution containing 2 mM Mn2þ instead of Ca2þ in order to quench
the fura-2 £uorescence. The calibration of the 340/380-nm ratio in
terms of free Ca2þ concentration was based on the procedure de-
scribed by Grynkiewicz et al. [22].
2.4. Statistics
All data are given as meansRS.E.M. The statistical signi¢cance of
di¡erences between mean values was assessed using Student’s t-test.
Di¡erences were regarded as statistically signi¢cant for P6 0.05.
3. Results
3.1. E¡ects of extracellular ATP on [Ca2þ]i in cultured
cortical astrocytes
Calcium-imaging analysis showed that in cultured rat cor-
tical type-1 astrocytes the mean resting [Ca2þ]i was 97.2R 7.4
nM (meanRS.E.M.; n=170). Upon prolonged (up to 8 min)
administration of 3 WM ATP, approximately 80% of the re-
sponding cells exhibited biphasic [Ca2þ]i responses, which
consisted of an initial, large transient component, and a small-
er sustained phase that showed little or no inactivation during
ATP application (Fig. 1A). The amplitude of the initial
[Ca2þ]i transient depended on ATP concentration with a
half-maximal increase (EC50) at 2.2 WM ATP and a Hill co-
e⁄cient of 1.5 (Fig. 1B). The magnitude of the sustained
phase was also dose-dependent with an EC50 of 0.9 WM and
a Hill coe⁄cient of 1.4 (Fig. 1C). The threshold for the Ca2þ
elevation above basal levels was approximately 0.3 WM ATP
for both the peak and the plateau phase and the maximal
activation was reached in the presence of 100 WM ATP. In
contrast to the transient [Ca2þ]i response, the sustained in-
crease was rapidly abolished by omitting extracellular Ca2þ
and addition of 0.5 mM EGTA, or application of either 10
WM La3þ or 100 WM Zn2þ, but was una¡ected by 10 WM
nifedipine, an antagonist of L-type voltage-activated Ca2þ
channels. Thus, it can be concluded that whereas the [Ca2þ]i
transient is due to ATP-evoked Ca2þ release from intracellular
stores, the sustained [Ca2þ]i elevation is mediated by Ca2þ
in£ux through the plasma membrane. Interestingly, the dy-
namics of the [Ca2þ]i responses triggered by ATP varied de-
pending on the duration of agonist application as a brief
challenge of about 20 s resulted only in a transient [Ca2þ]i
rise followed by a fast decline to the resting level. Only when
 
 
 
Fig. 1. ATP-mediated [Ca2þ]i responses in rat cortical astroglial
cells. A: ATP (3 WM; horizontal bar) evoked [Ca2þ]i increase in cul-
tured type-1 astrocytes. The typical response consisted of a transient
increase followed by a sustained elevation in [Ca2þ]i, which lasted
on ATP application. B,C: Concentration dependence of the ATP-in-
duced transient (B) and sustained [Ca2þ]i increases (C). The [Ca2þ]i
elevations were normalized to the maximal responses, which were
elicited by 100 WM ATP. The ¢t by the Hill equation yielded an
EC50 of 2.2 WM (B) and 0.9 WM (C). Data are the average of sev-
eral [Ca2þ]i values and each point is the mean of at least 12 astro-
cytes; error bars indicate S.E.M.
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the application of ATP was prolonged, the [Ca2þ]i plateau
could be observed (n=22; Fig. 2A). The result that such
di¡erential behavior was observed in the same astrocyte rules
out the possibility of an intercellular variability in the ATP-
mediated [Ca2þ] responses and supports the notion that di¡er-
ent unrelated cellular mechanisms are involved. This indica-
tion was also corroborated by experiments showing that
whereas the transient response was still largely desensitized
after a 5-min time interval before a second ATP challenge,
upon the same experimental paradigm the steady-state [Ca2þ]i
elevation was una¡ected compared to the ¢rst ATP applica-
tion (Ps 0.05, n=17; Fig. 2B).
3.2. E¡ects of P2 purinoceptor agonists on [Ca2þ]i in cortical
astrocytes
Since ATP is a non-selective P2 purinoceptor agonist, we
next characterized the [Ca2þ] responses elicited by agonists of
P2Y and P2X receptor subfamilies. A prolonged bath appli-
cation of the P2Y receptor agonist 2-methylthio-ATP (2-Me-
SATP; 10 WM; n=20) evoked a transient [Ca2þ]i rise that
decayed towards basal level with two time constants of
6.4 R 0.8 and 130.1 R 20.2 s (n=12; Fig. 3A). The pro¢le
of these responses was not signi¢cantly di¡erent (Ps 0.05)
from that observed when the 1.8 mM extracellular Ca2þ was
replaced and 0.5 mM EGTA added (time constants of
3.9 R 0.1 and 106.4R 13.9 s; n=8; data not shown). Notewor-
thy, this behavior of the [Ca2þ]i response was also observed
upon astrocyte challenge with UTP (100 WM; n=22; data not
shown). Collectively, these results suggest that P2Y2/4 recep-
 
 
 
Fig. 2. The transient and sustained [Ca2þ]i rises are two distinct mo-
lecular events. A: Representative [Ca2þ]i responses obtained by
changing the duration of the ATP (3 WM) application. Note that in
the same astrocyte brief challenge (20 s) evoked only a transient re-
sponse, whereas a long (3 min) application produced a biphasic
[Ca2þ]i signal composed of a peak and a sustained phase. B: The
[Ca2þ]i peak of the biphasic response was substantially diminished
when a second ATP challenge was performed 5 min later. By con-
trast, the plateau was not signi¢cantly altered, to indicate that the
two kinetically di¡erent [Ca2þ]i signals undergo di¡erential desensiti-
zation patterns.
Fig. 3. Di¡erent P2 purinoceptor agonists evoke kinetically variable [Ca2þ]i responses. A: Bath application of the P2Y agonist 2-MeSATP (10
WM) evoked only a transient [Ca2þ]i increase that returned in about 3 min to the resting [Ca2þ]i level with double exponential temporal ki-
netics. B: The selective P2X7 agonist Bz-ATP (10 WM) evoked a small peak, which was followed by a [Ca2þ]i plateau similar to that induced
by ATP application. C: Of the several P2 agonists tested the P2Y and P2X7 agonists generated a transient [Ca2þ]i response, whereas the
P2X1/3 agonist LQ-meATP (10 WM) was ine¡ective. D: When the same agents were assayed for their ability to elicit a sustained [Ca2þ]i eleva-
tion, only ATP and Bz-ATP evoked a [Ca2þ]i plateau measured 4 min after starting the agonist application. Results are presented as [Ca2þ]i in-
creases above basal levels and are expressed as meansRS.E.M.
FEBS 27025 28-2-03
M. Nobile et al./FEBS Letters 538 (2003) 71^76 73
tor subtypes are involved in the ATP-evoked transient [Ca2þ]i
signal in cortical type-1 astrocytes. The observation that the
[Ca2þ]i dynamics was not altered by omission of extracellular
Ca2þ strongly indicates that under our experimental condi-
tions activation of P2Y metabotropic receptors does not pro-
mote CCE. Whereas bath application of the P2X1/3 receptor
agonist L,Q-methylene-ATP (L,Q-meATP; 10 WM; n=13) did
not have any signi¢cant e¡ect (Ps 0.05) on [Ca2þ]i homeo-
stasis, the selective P2X7 agonist 3P-O-(4-benzoyl)benzoyl-
ATP (Bz-ATP; 10 WM; n=19) evoked a small [Ca2þ]i peak
followed by a plateau phase similar to that observed upon
ATP application (Fig. 3B). Figs. 3C and D separately show
the average transient and sustained [Ca2þ]i increases above
basal levels, evoked by individual applications of UTP (100
WM), 2-MeSATP (10 WM), L,Q-meATP (10 WM), Bz-ATP (10
WM) compared with response elicited by 10 WM ATP. The
data in Fig. 3D indicate that among the various P2 purino-
ceptor agonists tested only ATP and Bz-ATP evoked sus-
tained [Ca2þ]i responses. The sustained [Ca2þ]i elevations
above basal levels were 138.1 R 11.0 nM for 10 WM ATP
(n=30) and 147.5 R 28.1 nM for 10 WM Bz-ATP (n=19).
3.3. E¡ects of Bz-ATP on [Ca2þ]i in cultured cortical
astrocytes
When Bz-ATP was administered in the absence of extracel-
lular Ca2þ, the cells exhibited only a transient [Ca2þ]i response
and a sustained increase developed only after re-addition of
extracellular Ca2þ (Fig. 4A; n=12). These data indicate that
activation of the P2X7-like receptor in cortical astrocytes also
promotes Ca2þ mobilization from intracellular stores. In the
presence of 100 WM Zn2þ or 10 WM La3þ the Bz-ATP-induced
[Ca2þ]i plateau was completely and reversibly abrogated (Fig.
4B; n=14). Moreover, removal of extracellular Mg2þ caused
a 100% increase in the Bz-ATP-evoked [Ca2þ]i signal (data
not shown; n=8). Next, we veri¢ed the additivity of the
ATP- and Bz-ATP-mediated Ca2þ in£ux. As shown in Fig.
4C, Bz-ATP (10 WM) did not signi¢cantly (Ps 0.05) a¡ect the
ATP-induced [Ca2þ]i plateau (n=13), thus suggesting that the
two agonists may share the same plasma membrane Ca2þ
entry pathway. In order to discern whether the Bz-ATP-in-
duced, sustained [Ca2þ]i response was mediated by store-de-
pendent or store-independent pathways, we explored the e¡ect
of Bz-ATP on CCE induced by administration of cyclopia-
zonic acid (CPA), an inhibitor of the endoplasmic reticulum
Ca2þ-ATPase. In Fig. 4D is shown that after depletion of the
intracellular Ca2þ stores by CPA in Ca2þ-free solution (extra-
cellular Ca2þ replaced and addition of 0.5 mM EGTA), a
sustained [Ca2þ]i increase could be observed upon re-addition
of Ca2þ. When Bz-ATP (10 WM) and CPA (10 WM) were co-
applied in the presence of external Ca2þ, the evoked [Ca2þ]i
rise was signi¢cantly enhanced by about 30% compared to
CPA alone (P6 0.05; n=9), which indicates that the Bz-
ATP-evoked Ca2þentry is not mediated by CCE.
3.4. E¡ects of P2 purinoceptor antagonists
To get further insights into the properties of the P2 puri-
noceptors involved in the ATP-induced [Ca2þ]i signals in
cortical astrocytes, we analyzed the e¡ects of suramin
(Sura), pyridoxalphosphate-6-azophenyl-2P,4P-disulfonic acid
(PPADS) and oxidized ATP (oATP) on both ATP- and Bz-
ATP-stimulated [Ca2þ]i increases. As shown in Fig. 5A, 10
WM Sura, a broad-spectrum P2 antagonist, had di¡erential
e¡ects on the transient and sustained Ca2þ signals: whereas
Sura completely and reversibly blocked the transient [Ca2þ]i
increase induced by 1 WM ATP, it reduced by about 70% the
sustained component (n=9). The best ¢t of the dose^response
curve relative to the Sura blockade of the ATP-induced
[Ca2þ]i plateau depicts a half-e¡ective concentration (IC50)
of 3.7 WM with a Hill coe⁄cient of 1.2. Importantly, Sura
(30 WM) completely depressed the plateau phase induced by
10 WM Bz-ATP (Fig. 5B; n=12). Likewise, PPADS (30 WM;
n=20), another non-selective P2 antagonist, had inhibitory
 
 
 
 
 
 
Fig. 4. Characterization of the Bz-ATP-evoked [Ca2þ]i signal. A: When Bz-ATP (10 WM) was administered in the absence of extracellular Ca2þ
only a transient [Ca2þ]i elevation was observed; upon re-addition of extracellular Ca2þ, [Ca2þ]i rose to a steady-state level, which lasted over
the Bz-ATP challenge. B: The plateau phase of the Bz-ATP-induced [Ca2þ]i increase was reversibly inhibited by application of 100 WM Zn2þ.
C: The stimulation of the sustained [Ca2þ]i signal by Bz-ATP was not additive to that of ATP (10 WM). D: After exposure to CPA in a Ca2þ-
free solution to evoke CCE, the [Ca2þ]i responses elicited following Ca2þ re-addition were greater upon co-application of Bz-ATP.
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e¡ects on the ATP- and Bz-ATP-induced sustained [Ca2þ]i
elevations which were qualitatively similar to those obtained
with Sura (data not shown). The likely involvement of P2X7
receptors as molecular entity underlying the sustained [Ca2þ]i
increase was further corroborated by the observation that the
selective P2X7 antagonist oATP irreversibly reduced the ATP-
elicited [Ca2þ]i plateau without a¡ecting the transient compo-
nent. Fig. 5C shows that after a 2-h preincubation with 100
WM oATP, ATP (10 WM) induced only a transient [Ca2þ]i
elevation (n=11). The blockage was irreversible as even
upon prolonged oATP washing, a new ATP challenge evoked
solely a transient response. It is worth noting that Sura,
PPADS and oATP did not have any e¡ect on the [Ca2þ]i
signal elicited by CPA-mediated CCE (n=15; data not
shown). Taken together, these results add support to the tenet
that in cultured astroglial cells the ATP-induced transient
[Ca2þ]i elevation and the [Ca2þ]i plateau are dependent on
the activation of di¡erent subtypes of P2 purinoceptors, and
suggest that the sustained [Ca2þ]i signalling is mediated by
activation of Ca2þpermeable P2X7-like receptors.
4. Discussion
In the present study we provide evidence that in cultured
rat type-1 cortical astrocytes the sustained [Ca2þ]i elevation
which follows the [Ca2þ]i transient induced by prolonged ap-
plication of ATP at concentrations lower than 100 WM is
mediated by Ca2þ in£ux across the plasma membrane caused
by activation of P2X7 purinoceptors. We also show that CCE
contributes marginally, if at all, to the ATP-induced sustained
[Ca2þ]i rise. In some experiments [Ca2þ]i oscillations were
superimposed on the plateau [Ca2þ]i responses. There is evi-
dence that in astrocytes metabotropic receptor-mediated
[Ca2þ]i oscillations depend on agonist concentration and
that extracellular Ca2þ is required for such oscillatory activity
(for a review, see [13]). In our experiments the appearance of
oscillatory responses did not seem to depend on ATP concen-
tration. In this context, further work will be necessary to
identify the cellular mechanisms underlying [Ca2þ]i oscilla-
tions and to address their biological signi¢cance.
Three main categories of Ca2þ-permeable channels have
been reported to mediate Ca2þ entry from the extracellular
space [8] : voltage-operated Ca2þ channels, ligand-gated non-
speci¢c cation channels and receptor-dependent Ca2þ chan-
nels further subdivided into store-operated (or capacitative
Ca2þ channels) and non-capacitative Ca2þ channels regulated
independently of store depletion. The existence of store-oper-
ated channels in astrocytes and glioma cells has been recently
demonstrated [10,14,15,23,24]. Wu et al. [24] reported that
intracellular ATP levels are important for the maintenance
of the [Ca2þ]i plateau, and Rzigalinski et al. [15] suggested
that 5,6-epoxyeicosatrienoic acid is a molecular component
of the intracellular signalling cascade coupling store depletion
to Ca2þ entry in cultured cortical astrocytes. Moreover, the
involvement of non-capacitative Ca2þ entry mechanisms was
suggested to contribute to the hypoosmolarity- and histamine-
induced [Ca2þ]i responses in cultured rat astrocytes [10,23].
Finally, a novel mechanism of [Ca2þ]i elevation mediated by
Ca2þ in£ux has been demonstrated to underlie part of the
astrocytic [Ca2þ]i signal induced by activation of P2 purino-
ceptors. Such a mechanism requires the presence of a plasma-
lemma Ca2þ-permeable ionotropic receptor (P2X7), which is
activated by high ATP concentrations and is also able to
generate several biochemical responses [17^20]. The presence
of CCE through store-operated Ca2þ channels in our astro-
cytic cultures could be depicted from experiments in extracel-
lular Ca2þ-free conditions by using CPA to empty Ca2þ
stores. Under these conditions, upon Ca2þ re-addition astro-
cytes displayed a sustained Ca2þ in£ux, which was not af-
fected by the ATP receptor antagonists. The data that the
ATP-induced [Ca2þ]i plateau was abolished by divalent cati-
ons cannot be taken as an indication for the involvement of
CCE in the ATP-elicited sustained [Ca2þ]i rise because also
recombinant P2X7 channels were shown to be inhibited by
micromolar concentrations of various divalent cations [25].
An argument suggesting the involvement of P2X7 receptors
rather than CCE in the ATP-induced sustained [Ca2þ]i signal
is the result that, in addition to the blockade by the broad-
spectrum ATP receptor antagonists Sura and PPADS, the
[Ca2þ]i plateau was nearly completely inhibited by application
of the selective P2X7 antagonist oATP. Finally, the selective
P2X7 agonist Bz-ATP induced a Ca2þ entry that occluded the
Ca2þ in£ux elicited by ATP. Hence, even though CCE can be
 
 
 
 
 
 
 
Fig. 5. E¡ects of P2 purinoceptor antagonists on astroglial [Ca2þ]i
increase. A: ATP-induced [Ca2þ]i responses in the absence or pres-
ence of 10 WM Sura. Sura was applied 30 s before the addition of
1 WM ATP. At this concentration Sura had di¡erential e¡ects on
the transient and sustained [Ca2þ]i elevations, being more e¡ective
on the peak. B: A higher Sura concentration (30 WM) fully blocked
the [Ca2þ]i plateau induced by 10 WM Bz-ATP. This concentration
also completely abrogated the ATP-mediated sustained [Ca2þ]i ele-
vation. C: The [Ca2þ]i signal evoked by 10 WM ATP after a 2-h as-
trocyte preincubation with 100 WM oATP consisted only of a transi-
ent response. Note the irreversibility of the oATP e¡ect as depicted
by the observation that a second ATP challenge after more than 10
min of oATP washout evoked only a [Ca2þ]i transient.
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activated under our experimental conditions, it does not con-
tribute substantially to the ATP-mediated sustained [Ca2þ]i
response. This ¢nding is in contrast with previous studies
which, based on divalent sensitivity, postulated that the
ATP-induced [Ca2þ]i plateau was mediated by a store-oper-
ated Ca2þ in£ux [26]. A notable di¡erence between our data
and those previously reported in other astrocytic preparations,
in which higher concentrations were utilized (s 100 WM), is
the requirement of relatively low levels of ATP (6 100 WM) to
cause a Ca2þ in£ux mediated by P2X7-like receptors [18,20].
The reason for this discrepancy is unknown. However, since
in those studies a type-2 astrocytic cell line was used, the
di¡erential expression of P2X7 isoforms with di¡erent ATP
sensitivity cannot be ruled out. By contrast, the possibility
that heteromeric channels formed by the subunit interactions
between P2X7 and other P2X receptor subtypes present in
cultured cortical astrocytes is unlikely because recent work
had shown that in astroglial cells P2X7 receptor exists as a
monomer [27].
It is well established that in vitro extracellular ATP stimu-
lates proliferation and causes changes in astrocyte morphol-
ogy, including process extension and thickening [28^30]. In
vivo, such a change in astrocytic morphology is called reactive
astrogliosis and is observed as a result of several pathological
insults [31,32]. The hypothesis that P2 purinoceptors may play
a role in the astrocyte reaction to brain injuries was recently
con¢rmed by the observation that in vivo activation of P2
receptors causes astrocyte proliferation and hypertrophy [5].
The activation of a G protein-coupled P2Y-like receptor was
proposed to underlie the proliferative action of ATP [33].
Moreover, by using various receptor antagonists, the possible
role of P2X7 in this trophic e¡ect could be ruled out [34].
Finally, a likely activation of P2Y receptor was shown to
have a causative role in astrocytic proliferation in vivo [5].
Our data that already low micromolar concentrations of
ATP evoke a signi¢cant, sustained elevation of cytoplasmic
calcium through extracellular Ca2þ entry via P2X7 receptors
suggest that this ionotropic purinoceptor may also have a role
in the physiological regulation of astroglial syncytium. Nota-
bly, there is evidence that P2X7 receptor stimulation activates
various intracellular signalling pathways [18,19]. Moreover,
stimulation of P2X7 receptor in cultured astrocytes was re-
ported to increase the expression of chemokine MCP-1 [19]
and to regulate the release of purines [17]. Since the regulated,
Ca2þ-dependent secretion of neurotransmitters and neuromo-
dulators from astroglia has been postulated to play a crucial
role in neuron^astroglia communication [1], and because of
the importance that ATP-mediated [Ca2þ]i dynamics may
have in such interaction [35], this study indicates that astro-
glial P2X7 receptor may be involved in the control of the
excitability of the neuronal network.
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